HT
OLMA icon

Headlands Technologies’s Olema Pharmaceuticals OLMA Stock Holding History

Headlands Technologies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Sell
41,242
-18,132
-31% -$243K 0.05% 403
2026
Q1 		$885K Buy
+59,374
New +$1.32M 0.1% 235

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Headlands Technologies's OLMA Position: Q2 2026 in Review

Headlands Technologies reduced its Olema Pharmaceuticals (OLMA) stake by 31% in Q2 2026, selling an estimated $243K and leaving 41,242 shares worth $516K. The position accounts for 0.05% of the portfolio, ranked #403.

Headlands Technologies first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $885K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Headlands Technologies held 41,242 shares of Olema Pharmaceuticals worth $516K as of Q2 2026.
  • Headlands Technologies sold 18,132 Olema Pharmaceuticals shares in Q2 2026, an estimated $243K.
  • Olema Pharmaceuticals made up 0.05% of Headlands Technologies's portfolio in Q2 2026, its #403 holding.
  • Headlands Technologies first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Headlands Technologies's Olema Pharmaceuticals position peaked at $885K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.